Highlights Biohit Oyj

Equities

BIOBV

FI0009005482

Delayed Nasdaq Helsinki Other stock markets 10:44:09 2024-04-30 am EDT			5-day change	1st Jan Change
2.01 ^EUR	+0.50%		-0.50%	+6.63%

Apr. 15	Faron Pharmaceuticals reappoints former finance chief on interim basis	AN
Feb. 14	Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14	CI
Biohit Oyj Provides Earnings Guidance for the Period from 2024 to 2028	Nov. 22	CI
Biohit Revises Earnings Guidance for 2023	23-08-09	CI
Biohit Oyj Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-09	CI
Biohit Oyj Provides Earnings Guidance for the Year 2023	23-02-15	CI
Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-15	CI
Biohit Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-15	CI
Biohit Oyj Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-10	CI
Biohit Oyj Revises Earnings Guidance for the Year 2022	22-08-03	CI
Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-16	CI
Biohit Oyj Provides Earnings Guidance for the Year 2022	22-02-16	CI
Biohit Oyj Specifies Financial Guidance for 2021	22-02-08	CI
Biohit Oyj Announces Recent Clinical Validation Study Confirms the Accuracy of the New-Generation GastroPanel Test in Diagnosis of Atrophic Gastritis and Helicobacter Pylori Infection	21-12-14	CI
Biohit Provides Revenue Guidance for the Year 2021	21-08-11	CI
Biohit Oyj Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-11	CI
Biohit Oyj Provides Revenue Guidance for the Year 2021	21-02-17	CI
Biohit Oyj Provides Sales Guidance for 2020	20-08-12	CI
Biohit Oyj Revises Sales Guidance for the Year 2020	20-06-04	CI
Biohit Oyj Provides Net Sales Guidance for the First Half of 2020	20-06-04	CI
Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2019	20-02-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biohit Oyj

Equities

BIOBV

FI0009005482

Highlights

Filters